{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T14:41:18Z","timestamp":1780929678496,"version":"3.54.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10072-025-08757-9","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T03:20:01Z","timestamp":1768188001000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Unraveling fear of relapse in multiple sclerosis: beyond perfectionism and uncertainty"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3027-7863","authenticated-orcid":false,"given":"Christian","family":"Messina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"8757_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-025-08507-x","author":"YE Akbo\u011fa","year":"2025","unstructured":"Akbo\u011fa YE, T\u00fcrkel NN, Demirci A, Ertek \u0130E (2025) Fear of relapse in multiple sclerosis: examining the roles of perfectionism and intolerance of uncertainty. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-025-08507-x","journal-title":"Neurol Sci"},{"issue":"7","key":"8757_CR2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2174\/1570159X14666160106155129","volume":"14","author":"E Franscina Pinto","year":"2016","unstructured":"Franscina Pinto E, Andrade C (2016) Interferon-Related depression: A primer on Mechanisms, Treatment, and prevention of a common clinical problem. Curr Neuropharmacol 14(7):743\u2013748. https:\/\/doi.org\/10.2174\/1570159X14666160106155129","journal-title":"Curr Neuropharmacol"},{"key":"8757_CR3","doi-asserted-by":"publisher","unstructured":"Lai JY et al (2023) Interferon therapy and its association with depressive disorders \u2013 A review. Front Immunol 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1048592","DOI":"10.3389\/fimmu.2023.1048592"},{"key":"8757_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jad.2015.08.040","volume":"187","author":"SA Morrow","year":"2015","unstructured":"Morrow SA, Barr J, Rosehart H, Ulch S (2015) Depression and hypomania symptoms are associated with high dose corticosteroids treatment for MS relapses. J Affect Disord 187:142\u2013146. https:\/\/doi.org\/10.1016\/j.jad.2015.08.040","journal-title":"J Affect Disord"},{"issue":"4","key":"8757_CR5","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1177\/13524585211031128","volume":"28","author":"E Longinetti","year":"2022","unstructured":"Longinetti E, Frisell T, Englund S, Reutfors J, Fang F, Piehl F (2022) Risk of depression in multiple sclerosis across disease-modifying therapies. Multiple Scler J 28(4):632\u2013641. https:\/\/doi.org\/10.1177\/13524585211031128","journal-title":"Multiple Scler J"},{"issue":"5","key":"8757_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00415-025-13116-x","volume":"272","author":"DE Freedman","year":"2025","unstructured":"Freedman DE, Oh J, Einstein G, Feinstein A (2025) Aging and the neuropsychiatry of multiple sclerosis: a cross-sectional study. J Neurol 272(5):375. https:\/\/doi.org\/10.1007\/s00415-025-13116-x","journal-title":"J Neurol"},{"issue":"8","key":"8757_CR7","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00702-024-02792-0","volume":"131","author":"KA Jellinger","year":"2024","unstructured":"Jellinger KA (2024) Depression and anxiety in multiple sclerosis. Review of a fatal combination. J Neural Transm 131(8):847\u2013869. https:\/\/doi.org\/10.1007\/s00702-024-02792-0","journal-title":"J Neural Transm"},{"issue":"6","key":"8757_CR8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s00415-025-13167-0","volume":"272","author":"F Giofr\u00e8","year":"2025","unstructured":"Giofr\u00e8 F et al (2025) The topography of infratentorial lesions in depression and anxiety in multiple sclerosis. J Neurol 272(6):420. https:\/\/doi.org\/10.1007\/s00415-025-13167-0","journal-title":"J Neurol"},{"key":"8757_CR9","doi-asserted-by":"publisher","first-page":"100484","DOI":"10.1016\/j.bbih.2022.100484","volume":"24","author":"DS Peres","year":"2022","unstructured":"Peres DS et al (2022) Prevalence of depression and anxiety in the different clinical forms of multiple sclerosis and associations with disability: A systematic review and meta-analysis. Brain Behav Immun Health 24:100484. https:\/\/doi.org\/10.1016\/j.bbih.2022.100484","journal-title":"Brain Behav Immun Health"},{"key":"8757_CR10","doi-asserted-by":"publisher","first-page":"118192","DOI":"10.1016\/j.jns.2021.118192","volume":"429","author":"M Ben Abdallah","year":"2021","unstructured":"Ben Abdallah M et al (2021) The link between multiple sclerosis and depression. J Neurol Sci 429:118192. https:\/\/doi.org\/10.1016\/j.jns.2021.118192","journal-title":"J Neurol Sci"},{"key":"8757_CR11","doi-asserted-by":"publisher","unstructured":"Wang H, Wang R, Zhao R, Zhang G, Zhang G, Zhao X (2025) Fatigue and its correlation with anxiety and depression in patients with multiple sclerosis in China. Front Neurol 16. https:\/\/doi.org\/10.3389\/fneur.2025.1604540","DOI":"10.3389\/fneur.2025.1604540"},{"key":"8757_CR12","doi-asserted-by":"publisher","first-page":"105401","DOI":"10.1016\/j.neubiorev.2023.105401","volume":"154","author":"P Rodrigues","year":"2023","unstructured":"Rodrigues P, Silva Bda, Trevisan G (2023) A systematic review and meta-analysis of neuropathic pain in multiple sclerosis: Prevalence, clinical types, sex dimorphism, and increased depression and anxiety symptoms. Neurosci Biobehav Rev 154:105401. https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105401","journal-title":"Neurosci Biobehav Rev"},{"key":"8757_CR13","doi-asserted-by":"publisher","first-page":"111210","DOI":"10.1016\/j.jocn.2025.111210","volume":"135","author":"E Moases Ghaffary","year":"2025","unstructured":"Moases Ghaffary E et al (2025) Clinical and psychological factors associated with fear of relapse in people with multiple sclerosis: A cross-sectional study. J Clin Neurosci 135:111210. https:\/\/doi.org\/10.1016\/j.jocn.2025.111210","journal-title":"J Clin Neurosci"},{"key":"8757_CR14","doi-asserted-by":"publisher","unstructured":"Mallahzadeh A, Fereydoonnezhad T, Gauthier LV, Farjoud Kouhanjani M, Hosseinizadeh S, Khatibi A (2025) Fear of disease progression and relapse in multiple sclerosis: a systematic scoping review. Front Psychiatry 16. https:\/\/doi.org\/10.3389\/fpsyt.2025.1680781","DOI":"10.3389\/fpsyt.2025.1680781"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08757-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08757-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08757-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:04:01Z","timestamp":1773072241000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08757-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["8757"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08757-9","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not involve studies with human participants or animals and does not include individual patient data; therefore, neither ethical approval nor patient consent was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement and patient consent"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"142"}}